Discontinued — last reported Q4 '25
Current Assets
Prepaid & Other Current
Edwards Lifesciences Prepaid & Other Current decreased by 2.1% to $91.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8.4%, from $99.70M to $91.30M. Over 2 years (FY 2023 to FY 2025), Prepaid & Other Current shows a downward trend with a -7.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ4 2025
How to read this metric
Significant changes usually reflect timing differences in vendor payments or shifts in short-term operational requirements.
Detailed definition
Payments made in advance for goods or services to be received within one year, along with other miscellaneous short-term...
Peer comparison
Usually a small percentage of total assets for tech hardware firms, though it can spike during major production ramp-ups.
Metric ID:
prepaid_and_other_current_assetsHistorical Data
10 periods
| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $109.90M | $107.80M | $105.70M | $103.70M | $101.60M | $99.70M | $97.70M | $95.70M | $93.30M | $91.30M |
| QoQ Change | — | -1.9% | -1.9% | -1.9% | -2.0% | -1.9% | -2.0% | -2.0% | -2.5% | -2.1% |
| YoY Change | — | — | — | — | -7.6% | -7.5% | -7.6% | -7.7% | -8.2% | -8.4% |
Range$91.30M – $109.90M
CAGR-7.9%
Avg YoY Growth-7.8%
Median YoY Growth-7.6%
Current Streak9+ quarters decline
Prepaid & Other Current at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's prepaid & other current?
- Edwards Lifesciences (EW) reported prepaid & other current of $91.30M in Q1 2026.
- How has Edwards Lifesciences's prepaid & other current changed year-over-year?
- Edwards Lifesciences's prepaid & other current decreased by 8.4% year-over-year, from $99.70M to $91.30M.
- What is the long-term trend for Edwards Lifesciences's prepaid & other current?
- Over 2 years (2023 to 2025), Edwards Lifesciences's prepaid & other current has grown at a -7.9% compound annual growth rate (CAGR), from $109.90M to $93.30M.
- What does prepaid & other current mean?
- Bills paid in advance and other small assets that will be used up within the next twelve months.